title: Transperitoneal removal of osteocalcin, calcitonin and parathyroid hormone in patients treated by CAPD.
authors.forename: V
authors.initials: V
authors.lastname: Stefanović
authors.forename: M
authors.initials: M
authors.lastname: Mitić
authors.forename: E
authors.initials: E
authors.lastname: Golubović
authors.forename: M
authors.initials: M
authors.lastname: Rajić
authors.forename: V
authors.initials: V
authors.lastname: Avramović
authors.forename: I
authors.initials: I
authors.lastname: Ignjatović
mesh_terms: D002116:Calcitonin / Q000097:blood*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D015675:Osteocalcin / Q000097:blood*; D010281:Parathyroid Hormone / Q000097:blood*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010537:Peritoneum / Q000378:metabolism*
chemical_list: D010281:Parathyroid Hormone; D015675:Osteocalcin; D002116:Calcitonin